ViewMind Applauded by Frost & Sullivan for Its One-of-a-Kind Digital Biomarker Technology for Neurocognitive Disorders
#viewmind
#frost
#sullivan
#digitalbiomarkertechnology
3 years ago By Gomez — The AI-powered technology can enable early screening at scale for a range of neurocognitive conditions, such as Alzheimer's and mild cognitive impairment.